版本:
中国

BRIEF-Mirati Therapeutics Q1 loss per share $0.73

May 4 Mirati Therapeutics Inc:

* Mirati Therapeutics - expect currently available cash, cash equivalents and short-term investments sufficient to fund operations into late 2018

* Mirati Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $0.73

* Q1 earnings per share view $-0.79 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐